Veterinary Pain Management Market Demand Rises Growing at CAGR of 8.2% Top Player Revenue and New Opportunity Industry Forecast (2018-2023)

“Veterinary Pain Management”
Market Research Future published a cooked research report on “Veterinary Pain Management Market Research Report – By Major Industry Trends, Worldwide Pet Pain Management Industry Analysis, Major Segments and Sub segments. Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Veterinary Pain Management Market – Overview

Veterinary pain management is a very important aspect of veterinary therapeutics. The global market is driven by the rising adoption of pets, increasing preventive treatments and care facilities for companion animals, increasing technically advanced devices, raising awareness regarding maintaining animal health, and animal welfare.

The global veterinary pain management market is expected to register a CAGR of 8.2% during the forecast period.

Get Sample Report with Current Market Trend here https://www.marketresearchfuture.com/sample_request/5961

Veterinary Pain Management Market – Top Players

  • Boehringer Ingelheim
  • Zoetis, Chanelle
  • Dechra Pharmaceuticals
  • Ceva Santé Animale
  • Norbrook Laboratories
  • Vetoquinol, Bayer
  • Merck Animal Health
  • Elanco
  • Assisi Animal Health.

Global Veterinary Pain Management Market  – Regional Analysis

The Americas dominates the global veterinary pain management market due to the rising adoption of pets, increasing preventive treatments and care facilities for companion animals, increasing technically advanced devices, raising awareness regarding maintaining animal health and animal welfare, and growing penetration by market players. Additionally, factors such as the growing need for easy access to services and affordable veterinary drugs are likely to drive the market. According to a survey conducted by the National Pet Owners, in 2017, around 68% of families or households owned pets in the U.S. Additionally, according to the American Pet Products Association 69.4 billion was spent in pet healthcare expenditure in the U.S in 2016.

The European market is expected to grow at a strong growth rate during the forecast period owing to the availability of advanced treatment facilities and healthcare expenditure along with the growing pet adoption. Furthermore, increasing awareness and animal welfare are driving the growth of the veterinary pain management market. According to the European Pet Food Industry, in 2016, there were around 80 million households owning pets in Europe.

Asia Pacific is the fastest growing market for veterinary pain management whose growth is attributed to the increasing population adopting pets and the improved standard of living. Additionally, increasing healthcare spending is likely to drive the growth of the market. India and China are the major contributors to the market growth due to the rapid development of healthcare infrastructure in these regions and increasing demand for diagnostic and treatment services.

On the other hand, the Middle East and Africa is expected to witness slow growth due to limited access to healthcare and affordability issues among the population. In the Middle East, the growth of the market is driven by the increasing availability of new and advanced diagnostic and treatment methods for various veterinary ailments.

Avail Stunning Discount on Customize Reports –  https://www.marketresearchfuture.com/check-discount/5961

 

Global Veterinary Pain Management Market – Segmentation

The global veterinary pain management market is segmented on the basis of drug type, devices, route of administration, animal type, application, and end-user. Considering drug type, the market is segmented into nonsteroidal anti-inflammatory drugs, opioids, local anesthetics, α2-adrenergic agonists, muscle relaxants, sedatives, and corticosteroids. Nonsteroidal anti-inflammatory drugs are further sub-segmented into etodolac, fentanyl, and meloxicam. Opioids are further sub-segmented into morphine, hydromorphone, codeine, and others. Local anesthetics are further sub-segmented into bupivacaine, lidocaine, chloroprocaine, and others. α2-adrenergic agonists are further sub-segmented into xylazine, medetomidine, and others. By device, the market is segmented into laser therapy devices and electromagnetic therapy devices. Based on the route of administration, the market is segmented into oral, parenteral, and topical. With reference to animal type, the market is segmented into companion animals, livestock, research animals, aquatic animals, zoo animals, and exotic animals. Based on application it is segmented into joint pain, postoperative pain, and cancer. On account of end-user, the market is segmented into veterinary hospitals and clinics, research institutes, and universities and laboratories.

 

Some of the Major Table Of Content

1. Report Prologue         

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

 

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

 

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

 

Get Full TOC of the Report Here https://www.marketresearchfuture.com/enquiry/5961

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com